...
【24h】

Hypertension in women

机译:女性高血压

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hypertension is the most common modifiable risk factor for cardiovascular disease, the leading cause of death in both men and women. The prevalence and severity of hypertension rise markedly with age, and blood pressure control becomes more difficult with aging in both genders, particularly in women. In addition, there are forms of hypertension that occur exclusively in women, e.g., hypertension related to menopause, oral contraceptive use, or pregnancy (e.g., chronic hypertension, gestational hypertension, pre-eclampsia or eclampsia). Randomized controlled trials show that antihypertensive therapy provides similar reductions in major cardiovascular events in men and women. Therefore, gender should not influence decisions on selection of blood pressure lowering therapies, except for consideration of gender-specific side effects or contraindications for use in women who are or may become pregnant. This article reviews the prevalence, awareness, treatment, and control of hypertension in women, as well as recent guidelines for management of hypertension in women.
机译:高血压是心血管疾病最常见的可改变的危险因素,心血管疾病是男女死亡的主要原因。高血压的患病率和严重程度随着年龄的增长而显着增加,并且随着年龄的增长,男女的血压控制变得更加困难,尤其是女性。另外,某些形式的高血压仅在女性中发生,例如,与更年期,口服避孕药或妊娠有关的高血压(例如,慢性高血压,妊娠高血压,先兆子痫或子痫)。随机对照试验表明,降压治疗可减少男性和女性的主要心血管事件。因此,性别不应影响选择降压疗法的决定,除非考虑到性别特异性副作用或孕妇或可能怀孕妇女的禁忌症。本文回顾了女性高血压的患病率,认识,治疗和控制,以及有关女性高血压管理的最新指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号